Merck KGaA
MRK: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€648.00 | Cjjjl | Yfjyxpjg |
Merck KGaA Earnings: Weak Life Science and Electronics Segments Cut Into 2023 Outlook
Narrow-moat Merck KGaA delivered weak second-quarter results, and with these trends, management reduced its 2023 outlook. Mild tinkering with our near-term expectations does not materially affect our fair value estimates for the firm (EUR 171/$38), though, and shares continue to trade near fair value, in our opinion.